Low-intensity extracorporeal shock wave therapy for erectile dysfunction: Updated action mechanisms and application.
- Author:
Hai-Zhong XU
1
;
Yi-Ping NING
1
;
Xu-Kai YANG
2
Author Information
1. The First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, China.
2. Department of Urology, No. 940 Hospital of Chinese People's Liberation Army, Lanzhou, Gansu 730050, China.
- Publication Type:English Abstract
- Keywords:
erectile dysfunction;
low-intensity extracorporeal shock wave therapy;
phosphodieseterase 5 inhibitor
- MeSH:
Humans;
Male;
Erectile Dysfunction/therapy*;
Extracorporeal Shockwave Therapy
- From:
National Journal of Andrology
2025;31(1):69-75
- CountryChina
- Language:Chinese
-
Abstract:
Erectile dysfunction (ED) is a most common sexual dysfunction caused by various factors. Phosphodiesterase-5 inhibitors (PDE5i) are commonly used for the treatment of ED, but often with a poor effect for patients with moderate to severe ED and those with underlying diseases such as diabetes mellitus. Low-intensity extracorporeal shock wave therapy (Li-ESWT), as a novel non-invasive physical therapy, has the advantages of mild tissue damage, high safety and short treatment cycle. The effectiveness and safety of Li-ESWT in the treatment of ED has been preliminarily demonstrated by more than a decade of research and development, and its therapeutic effect evidently exhibited by significantly improving the symptoms of the ED patients with poor response to PDE5i. Researches on Li-ESWT are increasing at home and abroad, and its application in the treatment of ED has become a hot spot of attention. This review elaborates the action mechanisms and application of Li-ESWT in the treatment of ED, aiming to provide some new ideas for the clinical diagnosis and treatment of the condition.
